Zobrazeno 1 - 10
of 93
pro vyhledávání: '"Scott W. Mueller"'
Autor:
Matthew A. Miller, Douglas N. Fish, Gerard R. Barber, Michelle A. Barron, Tiffany A. Goolsby, Pierre Moine, Scott W. Mueller
Publikováno v:
Journal of Microbiology, Immunology and Infection, Vol 53, Iss 2, Pp 321-327 (2020)
Background: Methicillin-susceptible Staphylococcus aureus (MSSA) is a frequent cause of bloodstream infections (BSI). Treatment with nafcillin (NAF) has been preferred to cefazolin (CFZ). However, comparable outcomes have been found with CFZ with pos
Externí odkaz:
https://doaj.org/article/b142a1a075994e6bbff51a7bc80d82c6
Autor:
Victoria M. Stevens PharmD, BCCCP, Toby C. Trujillo PharmD, FCCP, FAHA, BCPS, Tyree H. Kiser PharmD, FCCM, FCCP, BCPS, Robert MacLaren PharmD, MPH, FCCM, FCCP, Paul M. Reynolds PharmD, BCCCP, Scott W. Mueller PharmD, BCCCP, FCCM, FCCP
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis, Vol 27 (2021)
The aim of this retrospective study was to compare andexanet alfa and 4-factor prothrombin complex (4F-PCC) for reversal of factor Xa (FXa)-inhibitor bleeding. Patients that received andexanet alfa for reversal were included. An equivalent number of
Externí odkaz:
https://doaj.org/article/aaafdc76bee8415cba4f83955f1243a6
Autor:
Edward T. Van Matre, Shelby L. Evans, Scott W. Mueller, Robert MacLaren, Douglas N. Fish, Tyree H. Kiser
Publikováno v:
Annals of Clinical Microbiology and Antimicrobials, Vol 18, Iss 1, Pp 1-7 (2019)
Abstract Background Invasive fungal infections are a major cause of morbidity and mortality. Newer antifungals may provide similar efficacy with improved safety compared to older more established treatments. This study aimed to compare clinically rel
Externí odkaz:
https://doaj.org/article/2b8f4cc5bb70448aac5aab4beba2a320
Autor:
Victoria M. Stevens PharmD, Toby Trujillo PharmD, FCCP, FAHA, BCPS-AQ Cardiology, Scott W. Mueller PharmD, BCCCP, FCCM, Robert MacLaren PharmD, FCCM, FCCP, Paul M. Reynolds PharmD, BCCCP, Tyree H. Kiser PharmD, FCCM, FCCP, BCPS
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis, Vol 25 (2019)
Andexanet alfa is approved for the reversal of factor Xa inhibitors in patients with major bleeding events. We aimed to review the incidence of effective hemostasis with andexanet alfa in a real-world environment. This retrospective cohort included p
Externí odkaz:
https://doaj.org/article/872f665bf08e410e97fa7dc0382f2cb3
Autor:
Whitley M. Yi, Kelly E. Schoeppler, Jaclyn Jaeger, Scott W. Mueller, Robert MacLaren, Douglas N. Fish, Tyree H. Kiser
Publikováno v:
Annals of Clinical Microbiology and Antimicrobials, Vol 16, Iss 1, Pp 1-14 (2017)
Abstract Background Therapeutic drug monitoring (TDM) aims to minimize the clinical impact of posaconazole and voriconazole pharmacokinetic variability. However, its benefits on clinical outcomes are still being defined. Additionally, TDM data are li
Externí odkaz:
https://doaj.org/article/e30344579ca149a49c0e111866248e61
Publikováno v:
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 43:321-337
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6c7117e2f4eb5e7ed2e0200324e0dbdb
https://doi.org/10.1002/phar.2794
https://doi.org/10.1002/phar.2794
Autor:
Alison R. Novak, Courtney Shakowski, Toby C. Trujillo, Garth C. Wright, Scott W. Mueller, Tyree H. Kiser
Publikováno v:
Journal of Thrombosis and Thrombolysis. 54:276-286
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c4ed30e2123ec493886c465aed70c29d
https://doi.org/10.1007/s11239-022-02668-8
https://doi.org/10.1007/s11239-022-02668-8
Publikováno v:
Open Forum Infectious Diseases. 10
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f673eefd7722ced26adeaf8bd11b1e01
https://doi.org/10.1093/ofid/ofad210
https://doi.org/10.1093/ofid/ofad210
Autor:
Kyle C. Molina, Matthew A. Miller, Scott W. Mueller, Edward T. Van Matre, Martin Krsak, Tyree H. Kiser
Publikováno v:
Clinical Pharmacokinetics. 61:363-374
Dalbavancin is a synthetic lipoglycopeptide that exerts its antimicrobial activity through two distinct modes of action, inhibition of cell wall synthesis and an anchoring mechanism. Compared with previous glycopeptide antibiotics, dalbavancin demons
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b8f07d1612b90ee0298136a6498d4df
https://doi.org/10.1007/s40262-021-01088-w
https://doi.org/10.1007/s40262-021-01088-w
Autor:
Scott W Mueller, Laura J Baumgartner, Rob MacLaren, Robert Neumann, Arek J Wiktor, Tyree H Kiser, Gordon Lindberg, Luis Cava, Douglas N Fish, Edward N Janoff
Publikováno v:
PLoS ONE, Vol 13, Iss 5, p e0197037 (2018)
Critically ill hospitalized patients are at increased risk of infection so we assessed the immunogenicity of 23-valent pneumococcal polysaccharide vaccine (PPSV23) administered within six days of injury.This prospective observational study compared t
Externí odkaz:
https://doaj.org/article/8c7a5fe9b72f474f8928130cc3816da9